Efficacy and Safety of Semaglutide Once-weekly Versus Placebo as add-on to SGLT-2i in Subjects With Type 2 Diabetes Mellitus
Clinical trial NCT03086330 · COMPLETED
Trial details
- NCT number
- NCT03086330
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-15
- Primary completion
- 2018-07-04
- Enrollment
- 302
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.